Article List

WPRIM Management System> DCMS> Diabetes & Metabolism Journal> 2019> 43> 5

Volume: 43 Issue: 5

1. Corrigenda: Table Correction. Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis	Page:731—731
2. Response: Increased Serum Angiopoietin-Like 6 Ahead of Metabolic Syndrome in a Prospective Cohort Study (Diabetes Metab J 2019;43:521-9)	Page:729—730
3. Letter: Increased Serum Angiopoietin-Like 6 Ahead of Metabolic Syndrome in a Prospective Cohort Study (Diabetes Metab J 2019;43:521-9)	Page:727—728
4. Low-Normal Free Thyroxine Levels in Euthyroid Male Are Associated with Prediabetes	Page:718—726
5. Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus	Page:711—717
6. Severity of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus: Relationship between Nongenetic Factors and PNPLA3/HSD17B13 Polymorphisms	Page:700—710
7. PF-04620110, a Potent Antidiabetic Agent, Suppresses Fatty Acid-Induced NLRP3 Inflammasome Activation in Macrophages	Page:683—699
8. The Association between Z-Score of Log-Transformed A Body Shape Index and Cardiovascular Disease in Korea	Page:675—682
9. Low-Frequency Intermittent Hypoxia Suppresses Subcutaneous Adipogenesis and Induces Macrophage Polarization in Lean Mice	Page:659—674
10. Essential Role of Protein Arginine Methyltransferase 1 in Pancreas Development by Regulating Protein Stability of Neurogenin 3	Page:649—658
11. Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study	Page:640—648
12. Longitudinal Changes of Body Composition Phenotypes and Their Association with Incident Type 2 Diabetes Mellitus during a 5-Year Follow-up in Koreans	Page:627—639
13. Association between Change in Alcohol Consumption and Metabolic Syndrome: Analysis from the Health Examinees Study	Page:615—626
14. Progression to Gestational Diabetes Mellitus in Pregnant Women with One Abnormal Value in Repeated Oral Glucose Tolerance Tests	Page:607—614
15. Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Korean Patients with Type 2 Diabetes Mellitus in Real-World Clinical Practice	Page:590—606
16. Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus	Page:582—589
17. An Age of Sodium-Glucose Cotransporter-2 Inhibitor Priority: Are We Ready?	Page:578—581
18. Mitochondrial Toxins and Healthy Lifestyle Meet at the Crossroad of Hormesis	Page:568—577
19. Contributing Factors to Diabetic Brain Injury and Cognitive Decline	Page:560—567
20. Regulation of Systemic Glucose Homeostasis by T Helper Type 2 Cytokines	Page:549—559